Výsledky vyhledávání

Akademický článek

HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis.

Autor: Fleites YA; Department of Clinical Trials, Luis Diaz Soto Hospital, Havana, Cuba., Aguiar J; Department of Vaccines, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., Cinza Z; Department of Vaccines, Clinical Trials Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., Bequet M; Department of Pharmaceuticals, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., Marrero E; Department of Quality Control Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., Vizcaíno M; Department of Clinical Trials, Luis Diaz Soto Hospital, Havana, Cuba., Esquivel I; Department of Clinical Trials, Luis Diaz Soto Hospital, Havana, Cuba., Diaz M; Department of Clinical Trials, Luis Diaz Soto Hospital, Havana, Cuba., Sin-Mayor A; Department of Clinical Trials, Luis Diaz Soto Hospital, Havana, Cuba., Garcia M; Department of Clinical Trials, Luis Diaz Soto Hospital, Havana, Cuba., Martinez SM; Department of Clinical Trials, Luis Diaz Soto Hospital, Havana, Cuba., Beato A; Department of Clinical Trials, Luis Diaz Soto Hospital, Havana, Cuba., Galarraga AG; Department of Clinical Trials, Luis Diaz Soto Hospital, Havana, Cuba., Mendoza-Mari Y; Department of Pharmaceuticals, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., Valdés I; Department of Vaccines, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., García G; Department of Quality Control Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., Lemos G; Department of Vaccines, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., González I; Department of Pharmaceuticals, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., Canaán-Haden C; Department of Pharmaceuticals, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., Figueroa N; Department of Vaccines, Clinical Trials Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., Oquendo R; Department of Vaccines, Clinical Trials Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., Akbar SM; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan., Mahtab MA; Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh., Uddin MH; Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh., Guillén GE; Department of Vaccines, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., Muzio VL; Department of Vaccines, Clinical Trials Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., Pentón E; Department of Vaccines, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., Aguilar JC; Department of Vaccines, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba.

Publikováno v: Euroasian journal of hepato-gastroenterology [Euroasian J Hepatogastroenterol] 2021 Jul-Dec; Vol. 11 (2), pp. 59-70.

Zobrazit plný text záznamu

Akademický článek

Gradual reduction of testosterone using a gonadotropin-releasing hormone vaccination delays castration resistance in a prostate cancer model.

Autor: Barranco JA; Department of Vaccines, Center for Genetic Engineering and Biotechnology, Camagüey, Camagüey 70100, Cuba., Millar RP; Mammal Research Institute and Centre for Neuroendocrinology, University of Pretoria, Pretoria, Gauteng 0028, South Africa; MRC Receptor Biology Unit, Institute for Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, Western Cape 7925, South Africa., Fuentes F; Department of Vaccines, Center for Genetic Engineering and Biotechnology, Camagüey, Camagüey 70100, Cuba., Bover E; Department of Vaccines, Center for Genetic Engineering and Biotechnology, Camagüey, Camagüey 70100, Cuba., Pimentel E; Center for Genetic Engineering and Biotechnology, Havana, Havana 10600, Cuba., Basulto R; Department of Vaccines, Center for Genetic Engineering and Biotechnology, Camagüey, Camagüey 70100, Cuba., Calzada L; Department of Vaccines, Center for Genetic Engineering and Biotechnology, Camagüey, Camagüey 70100, Cuba., Morán R; Department of Vaccines, Center for Genetic Engineering and Biotechnology, Camagüey, Camagüey 70100, Cuba., Rodríguez A; Medical University of Camagüey, Camagüey, Camagüey 70100, Cuba., Garay H; Center for Genetic Engineering and Biotechnology, Havana, Havana 10600, Cuba., Reyes O; Center for Genetic Engineering and Biotechnology, Havana, Havana 10600, Cuba., Castro MD; Department of Vaccines, Center for Genetic Engineering and Biotechnology, Camagüey, Camagüey 70100, Cuba., Bringas R; Center for Genetic Engineering and Biotechnology, Havana, Havana 10600, Cuba., Arteaga N; Department of Vaccines, Center for Genetic Engineering and Biotechnology, Camagüey, Camagüey 70100, Cuba., Toudurí H; Medical University of Camagüey, Camagüey, Camagüey 70100, Cuba., Rabassa M; Department of Vaccines, Center for Genetic Engineering and Biotechnology, Camagüey, Camagüey 70100, Cuba., Fernández Y; Medical University of Camagüey, Camagüey, Camagüey 70100, Cuba., Serradelo A; Department of Vaccines, Center for Genetic Engineering and Biotechnology, Camagüey, Camagüey 70100, Cuba., Hernández E; Department of Vaccines, Center for Genetic Engineering and Biotechnology, Camagüey, Camagüey 70100, Cuba., Guillén GE; Center for Genetic Engineering and Biotechnology, Havana, Havana 10600, Cuba.

Publikováno v: Oncology letters [Oncol Lett] 2016 Aug; Vol. 12 (2), pp. 963-970. Date of Electronic Publication: 2016 Jun 07.

Zobrazit plný text záznamu

Akademický článek

Immunotherapy of prostate cancer in a murine model using a novel GnRH based vaccine candidate.

Autor: Junco JA; Department of Cancer, Center for Genetic Engineering and Biotechnology of Camaguey, CP 70100, Apdo 387, Camaguey, Cuba. jesus.junco@cigb.edu.cu, Peschke P, Zuna I, Ehemann V, Fuentes F, Bover E, Pimentel E, Basulto R, Reyes O, Calzada L, Castro MD, Arteaga N, López Y, Garay H, Hernández H, Bringas R, Guillén GE

Publikováno v: Vaccine [Vaccine] 2007 Dec 05; Vol. 25 (50), pp. 8460-8. Date of Electronic Publication: 2007 Oct 04.

Zobrazit plný text záznamu

Akademický článek

Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.

Autor: Betancourt AA; Vaccine Division, Vaccine Clinical Trials Department, Center for Genetic Engineering and Biotechnology, PO Box 6162, Cubanacán, Playa, Havana City, Cuba. aristides.aguilar@cigb.edu.cu, Delgado CA, Estévez ZC, Martínez JC, Ríos GV, Aureoles-Roselló SR, Zaldívar RA, Guzmán MA, Baile NF, Reyes PA, Ruano LO, Fernández AC, Lobaina-Matos Y, Fernández AD, Madrazo AI, Martínez MI, Baños ML, Alvarez NP, Baldo MD, Mestre RE, Pérez MV, Martínez ME, Escobar DA, Guanche MJ, Cáceres LM, Betancourt RS, Rando EH, Nieto GE, González VL, Rubido JC

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2007 Sep; Vol. 11 (5), pp. 394-401. Date of Electronic Publication: 2007 Jan 24.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání